Wednesday, November 17, 2021 11:20:08 PM
If one spends the time looking at all the past involving Dr. Dent within these many years of SEC filings it will display various things to the beholder that reads deep into all this. Now doing what Dent is doing with Medicare is very very hard to be successful in the end.
As for up-listing we will sometime but if if investors look close enough they will see the same up-listing dream in "2019".
Dr Dent will use whatever stock in this company he can for the best value and if he can't do that with the best value he will let the gate open to offset his hand/funds then between that and running the OS between upward between 380 to 380 million shares will then need to reverse this plain and simple. I'm sure the seasoned trader knows this already and will not stay or stay long for we get any upward pump simply as watching past trades and everything just dandee at Health Linked but I don't see it that way anymore.
Again read all the filings to enlighten on the pros and cons.
This is as different as night is to day than NeoGenomic Corporation plus they were on the cutting edge where industry needed them not like our company where we need the industry. No doubt NeoGenomic was a very special idea plus early on Doug came in and was CEO and still is. Dent had many shares as he was in on the ground floor so was able to control Neogenomic for his time. Dent is loaded with HLYK share too so he only has so much time (when it comes to investors) unless you are going to be here 6 plus years from now.
Dr Dent will slowly but actually has done pretty good if you back away and look at this but counting the positives are looking like a time to shake my head and wonder just how deep I want to go with this. I doubt we will dump down low enough for me to bit but I still think this investment is in the best hands compared to 90 percent of these stocks.
Just be careful and read stay as positive or take profits when one can. Like I said prior I sold and bought more twice now so it isn't like I bought and couldn't sell I did that way I haven't a problem watching this peg to $1.25 share price and wish I could have but didn't. That sucks I could have and did twice to to gain shares not pull profit but if I would not have sold I would have been pissed. Even if this dumps and they close up shop which that will not happen I was able to buy and sell so I'm OK with share price but I do think I'm now negative. To me the horsepower is in the number of shares you have. Why do you think Dr Dent can smile :)
The Nasdaq jump has to be done with the right funds and power behind it and we will need MM's that will create the market for us. We will get hammered on that exchange too and actually we got a taste .54 cent 2 million dollar taste of that or thereabouts.
I'm staying but won't be posting every week.
I haven't seen the latest Proactive so I will close and go find that and listen as it can't bite you that is the one that is trying to also feed our mouths well sort of?
Have a great day and there will always be tomorrow regardless if one wishes to smile or not today.
Recent HLYK News
- HealthLynked Announces Fourth Quarter and Full Year 2023 Results Highlighted by 70% Reduction in Net Loss for Q4 • InvestorsHub NewsWire • 04/02/2024 12:00:00 PM
- HealthLynked Announces Exciting New Update with HealthLynked 3.2.0 - Transforming Patient-Care Through Innovation • InvestorsHub NewsWire • 03/26/2024 12:00:00 PM
- HealthLynked Corp Announces Chris Hall as New Chief Technology Officer • InvestorsHub NewsWire • 03/19/2024 12:00:00 PM
- HealthLynked Welcomes David Rosal as New Chief Financial Officer • InvestorsHub NewsWire • 03/13/2024 12:00:00 PM
- HealthLynked Welcomes Garrett Gardi to Its Advisory Board • InvestorsHub NewsWire • 02/28/2024 01:00:00 PM
- HealthLynked and CEO Dr. Michael Dent Featured in Health Documentary "Forever: The End of Aging," Now Available for Streaming • InvestorsHub NewsWire • 01/24/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/11/2024 08:57:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/27/2023 09:05:14 PM
- HealthLynked Unveils Advanced Search Functionality to Improve Patient Care • InvestorsHub NewsWire • 12/13/2023 01:00:00 PM
- HealthLynked Announces Q3 & Year-to-Date 2023 Financial Results, Highlighted by 8% Revenue Growth and Net Income Turnaround • InvestorsHub NewsWire • 11/15/2023 01:00:00 PM
- Introducing the New HealthLynked COVID-19 Tracker: A Comprehensive Tool for the Modern Pandemic Era • InvestorsHub NewsWire • 10/12/2023 12:00:00 PM
- HealthLynked Receives Medicare Shared Savings Net Proceeds from Sale of ACO Health Partners • InvestorsHub NewsWire • 10/09/2023 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/06/2023 08:05:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/06/2023 08:05:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/06/2023 08:05:28 PM
- HealthLynked Announces Patent Filing for ARI: A Revolutionary AI-Powered Healthcare Interface • InvestorsHub NewsWire • 10/03/2023 12:00:00 PM
- HealthLynked Achieves Key Milestone with Final $300,000 Payment from Sale of ACO Health Partners • InvestorsHub NewsWire • 09/05/2023 12:00:00 PM
- HealthLynked Announces Steady YoY Revenue Increase for Q2 & H1 2023, Highlighting Significant Net Income Boost • InvestorsHub NewsWire • 08/15/2023 12:21:37 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:12:45 PM
- HealthLynked Corp. Names Wall Street Veteran Mike Paisan to Strategic Investor Relations Role • InvestorsHub NewsWire • 08/01/2023 12:00:00 PM
- HealthLynked Provides Financial Update • InvestorsHub NewsWire • 06/21/2023 12:00:00 PM
- HealthLynked Unveils Major App Update, Enhancing Personalized Healthcare Experience • InvestorsHub NewsWire • 06/06/2023 12:00:00 PM
- HealthLynked Corp. Announces Appointment of Bill Crupi as Regional Manager of Healthcare Services • InvestorsHub NewsWire • 05/23/2023 12:00:00 PM
- Solid Revenue Growth and Earnings Define HealthLynked's Q1 2023 • InvestorsHub NewsWire • 05/16/2023 12:00:00 PM
FEATURED Element79 Gold Corp Reports Exceptionally High-Grade Results from Lucero • May 14, 2024 7:00 AM
VAYK Added New Manager for Expansion into $64 Billion Domestic Short-term Rental Market • VAYK • May 14, 2024 9:00 AM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM